January 2026

Parkinson's disease (PD) is the fastest-growing neurological disorder globally, with nearly 90,000 new diagnoses annually in the U.S. alone. The disease is driven by the aggregation of α-synuclein (α-syn), which destroys dopaminergic neurons. Current therapies, such as levodopa, only provide symptomatic ...